The legacy of Viagra, and its parent company copyright, presents a challenging case study for investors. At first a blockbuster drug, generating billions in sales , its exclusivity period created a flood of lower-priced alternatives , significantly eroding its market share . While specific firms may seek to capitalize on related treatments , the ex